WASHINGTON — Fifty congressional Democrats signed on to a letter advancing the pharmaceutical industry’s talking points — and now a drug pricing advocacy group is calling them out.
Patients for Affordable Drugs sent a letter this morning to Speaker Paul Ryan and House Minority Leader Nancy Pelosi, along with the 50 Democrats, condemning the members who signed on to a separate May 24 missive that supports one of the drug industry’s chief lobbying priorities: a change to their financial liability in the so-called “donut hole.”
The May 24 letter, led by Reps. Brad Schneider (D-Ill.) and Robin Kelly (D-Ill.), encouraged congressional leaders to relax a policy enacted earlier this year that put drug companies on the hook for a higher percentage of seniors’ prescription drug costs beginning in 2019 in Medicare’s “donut hole,” a gap in prescription drug coverage during which seniors have to pay more of their drug costs out of pocket.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
